LLY241227P800000
- 17.32
- 0.000.00%
Eli Lilly and Co Newsroom
Trump Launches Surprise Meme Coin Just Before Inauguration and Price Soars
Here's Why Jim Sees Eli Lilly and Company (LLY) as a Long-Term Buy
Trending Stocks as Wall Street Bounces Back With Strong Week
Why Is Cliff Asness Bullish On Eli Lilly and Company (LLY)?
Eli Lilly (NYSE:LLY) Is Increasing Its Dividend To $1.50
Weekly Buzz: Finally a Good Week for 2025
Wall Street Today: Trump's on Deck After Market Nearly Hits Year High
How Is The Market Feeling About Eli Lilly?
Hims & Hers Health Down 3% After BoA Says Q4 Revenue Could Be a Miss
Live Stock News: Market Climbs, TikTok Ban Confirmed, Intel for Sale, Week Ends with Positivity
Medicare Will Pay Less for Ozempic and Wegovy in 2027. The Price-Negotiation List Is Out. -- Barrons.com
BofA Spotlights Four Bulls and Two Bears: LLY, TGT, PYPL, MCK, AR, and EWBC
Novo Nordisk's Ozempic, Wegovy Among Drugs Chosen for US Medicare Price Talks
Even Lack of Trump Action Matters Now | Markets in 3 Minutes
Ozempic Among the Next Drugs Up for Price Negotiations -- WSJ
FDA Approves Expanded Use Of Eli Lilly's Ulcerative Colitis Drug For Crohn's Disease
Novo Nordisk Says Higher Wegovy Dose Caused Over 20% Weight Loss in Late-stage Trial
Guggenheim Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Cuts Target Price to $973
The Bull Market Faces a Trump 'Reality Check' Next Week, Says This Strategist
Express News | Eli Lilly : Guggenheim Cuts Target Price to $973 From $995